Bharat Parenterals Limited

Founded in 1992 and headquartered in Gujarat, India.

1992 | Vadodara, Gujarat (India) | Active
Last Updated: December 25, 2024

Bharat Parenterals Profile

Key Indicators

  • Authorised Capital ₹ 8.00 Cr
  • Paid Up Capital ₹ 6.89 Cr
  • Company Age 32 Year, 5 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 131.52 Cr
  • Satisfied Charges ₹ 4.12 Cr

About Bharat Parenterals

Bharat Parenterals Limited (BPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 03 September 1992 and has a history of 32 years and five months. Its registered office is in Vadodara, Gujarat, India.

It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 541096.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 6.89 Cr.

The company currently has active open charges totaling ₹131.52 Cr. The company has closed loans amounting to ₹4.12 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Bharat Parenterals Limited India are Jignesh Shah as CFO and Krutika Bhattbhatt as Company Secretary. Mukeshbhai Patel, Bharatkumar Desai, Hemang Shah, and Three other members serve as directors at the Company.

Company Details

  • Location

    Vadodara, Gujarat, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    bplindia.in

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    L24231GJ1992PLC018237

  • Company No.

    018237

  • Stock Symbol

    BSE : 541096

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    03 Sep 1992

  • Date of AGM

    02 Jul 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Listed

  • ROC Code

    Roc Ahmedabad

Industry

Pharma

Who are the key members and board of directors at Bharat Parenterals?

Executive Team (3)

NameDesignationAppointment DateStatus
Bharatkumar Desai Country flag representing In Managing Director03-Sep-1992Current
Jignesh Shah Country flag representing In CFO14-Aug-2018Current
Krutika Bhattbhatt Country flag representing In Company Secretary28-Oct-2023Current

Board Members (5)

NameDesignationAppointment DateStatus
Mukeshbhai Patel Country flag representing In Director 26-Sep-2020Current
Hemang Shah Country flag representing In Director 08-Jul-2010Current
Shaileshkumar Ghabhawala Country flag representing In Director 03-Aug-2017Current
Sanjay Shah Country flag representing In Director 02-Oct-2020Current
Zankhana Sheth Country flag representing In Director 14-Aug-2018Current

Financial Performance of Bharat Parenterals.

Bharat Parenterals Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Bharat Parenterals?

In 2023, Bharat Parenterals had a promoter holding of 73.84% and a public holding of 26.16%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹131.52 Cr

Satisfied Charges

₹4.12 Cr

Charges Breakdown by Lending Institutions

  • Axis Bank Limited : 99.54 Cr
  • Others : 30.00 Cr
  • Hdfc Bank Limited : 1.91 Cr
  • Axis Bank Ltd : 0.08 Cr

Latest Charge Details

DateLenderAmountStatus
16 Dec 2024Hdfc Bank Limited₹2.15 MOpen
21 Sep 2024Hdfc Bank Limited₹7.80 MOpen
31 Jul 2024Hdfc Bank Limited₹7.03 MOpen
06 Jul 2024Axis Bank Limited₹25.00 CrOpen
26 Jun 2024Others₹30.00 CrOpen

How Many Employees Work at Bharat Parenterals?

Bharat Parenterals has a workforce of 367 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Bharat Parenterals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bharat Parenterals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Bharat Parenterals

Recent activity within the organization

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.22 Cr with Charge ID 101015285 was registered on 16 Dec 2024.

    16 Dec 2024

  • Charges

    A charge registered on 01 Dec 2023 via Charge ID 100824867 with Hdfc Bank Limited was fully satisfied on 12 Dec 2024.

    12 Dec 2024

  • Charges

    A charge with Others of Rs. 30.00 Cr registered on 26 Jun 2024 with Charge ID 100950684 was modified on 27 Nov 2024.

    27 Nov 2024

  • Charges

    A charge registered on 25 Oct 2019 via Charge ID 100304601 with Hdfc Bank Limited was fully satisfied on 06 Nov 2024.

    06 Nov 2024

  • Charges

    A charge registered on 28 Sep 2015 via Charge ID 100037106 with Others was fully satisfied on 18 Oct 2024.

    18 Oct 2024

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.78 Cr with Charge ID 100978023 was registered on 21 Sep 2024.

    21 Sep 2024

Frequently asked questions

  • Bharat Parenterals Limited was incorporated on 03 Sep 1992.

  • The authorized share capital of Bharat Parenterals Limited is ₹ 8.00 Cr and paid-up capital is ₹ 6.89 Cr.

  • Currently 8 directors are associated with Bharat Parenterals Limited.

    • Mukeshbhai Jivrajbhai Patel
    • Bharatkumar Rameshchandra Desai
    • Hemang Jayendrabhai Shah
    • Shaileshkumar Ghabhawala
    • Jignesh Nitinchandra Shah
    • Krutika Padmakar Bhattbhatt
    • Sanjay Parasmal Shah
    • Zankhana Bimalkumar Sheth
  • As per Ministry of Corporate Affairs (Mca), the registered address of Bharat Parenterals Limited is Survey No. 144A Jarod-Samlaya Road Haripura, Savli India, Vadodara, Gujarat, 391520.

  • The corporate identification number (CIN) of Bharat Parenterals Limited is L24231GJ1992PLC018237 and the company number is 018237 as per Ministry of Corporate Affairs (MCA).

  • Yes, Bharat Parenterals Limited is registered on Bombay Stock Exchange (BSE).

  • The Official website of Bharat Parenterals Limited is https://www.bplindia.in

  • As Per 2024 financial reports, 367 employees are currently employed by Bharat Parenterals Limited.

  • As per the financial statements for fiscal Year 2024, The total open charges for Bharat Parenterals Limited amount to ₹ 131.52 Cr.

  • The most recent Balance Sheet for Bharat Parenterals Limited was filed with the ROC on 31 Mar 2024.

Similar Companies Based on Drug Formulation & Development